Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Ardelyx Inc before investing.

In this article, we go over a few key elements for understanding Ardelyx Inc’s stock price such as:

• Ardelyx Inc’s current stock price and volume
• Why Ardelyx Inc’s stock price changed recently
• Upgrades and downgrades for ARDX from analysts
• ARDX’s stock price momentum as measured by its relative strength

About Ardelyx Inc (ARDX)

Before we jump into Ardelyx Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. It has two commercial products IBSRELA (tenapanor) and XPHOZAH. Its product pipeline includes RDX013 Program and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control of hyperphosphatemia or serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). XPHOZAH is a medicine for the control of serum phosphorus in adult patients with CKD on dialysis. RDX013 Program is a small molecule potassium secretagogue program for the treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis.

Want to learn more about Ardelyx Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Ardelyx Inc.

Ardelyx Inc’s Stock Price as of Market Close

As of September 11, 2024, 3:59 PM, CST, Ardelyx Inc’s stock price was $5.96.

Ardelyx Inc is up 4.75% from its previous closing price of $5.69.

During the last market session, Ardelyx Inc’s stock traded between $5.62 and $5.75. Currently, there are 234.57 million shares of Ardelyx Inc stock available for purchase.

Unfortunately, Ardelyx Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Ardelyx Inc Stock Price History

Ardelyx Inc’s (ARDX) price is currently down 3.56% so far this month.

During the month of September, Ardelyx Inc’s stock price has reached a high of $6.25 and a low of $5.49.

Over the last year, Ardelyx Inc has hit prices as high as $10.13 and as low as $3.16. Year to date, Ardelyx Inc’s stock is up 109.12%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Ardelyx Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 10, 2024, there was 1 analyst who downgraded Ardelyx Inc’s stock and 9 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Ardelyx Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Ardelyx Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Ardelyx Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Ardelyx Inc (ARDX) by visiting AAII Stock Evaluator.

Relative Price Strength of Ardelyx Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 10, 2024, Ardelyx Inc has a weighted four-quarter relative price strength of -1.08%, which translates to a Momentum Score of 59 and is considered to be Average.

Want to learn more about how Ardelyx Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Ardelyx Inc Stock Price: Bottom Line

As of September 11, 2024, Ardelyx Inc’s stock price is $5.96, which is up 4.75% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Ardelyx Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.